Adverse Hair Reactions to New Targeted Therapies for Cancer

    March 2019 in “ Actas Dermo-Sifiliográficas ”
    Juan Francisco Mir-Bonafé, David Saceda-Corralo, Sergio Vañó-Galván
    Studysummary This review discusses the adverse effects on hair associated with targeted cancer therapies and reports no new clinical results; it emphasizes the need for comprehensive documentation of these effects.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on doi.org →
    Discuss this study in the Community →

    Research cited in this study 28

    1. Case of Alopecia Induced by Sorafenib, Possible Mechanism Similar to Alopecia Areata The Journal of Dermatology · 2017
    2. Hair Repigmentation Associated With the Use of Brentuximab JAAD Case Reports · 2017
    3. Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management PubMed · 2017
    4. From Basal Cell Carcinoma Morphogenesis to Alopecia Induced by Hedgehog Inhibitors: Connecting the Dots British Journal of Dermatology · 2017
    5. Trichoscopic Findings of Erosive Pustular Dermatosis of the Scalp Associated with Gefitinib Case Reports in Dermatology · 2017
    6. Taiwanese Dermatological Association Consensus for the Prevention and Management of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Related Skin Toxicities Journal of the Formosan Medical Association · 2017
    7. Immune-Related Alopecia (Areata and Universalis) in Cancer Patients Receiving Immune Checkpoint Inhibitors British journal of dermatology/British journal of dermatology, Supplement · 2016
    8. Persistently Curly Hair Phenotype With the Use of Nivolumab for Squamous Cell Lung Cancer Journal of oncology pharmacy practice · 2016
    9. Alopecia Areata After Denosumab Treatment for Osteoporosis JAAD case reports · 2016
    10. Hair and Nail Adverse Events During Treatment with Targeted Therapies for Metastatic Melanoma European journal of dermatology/EJD. European journal of dermatology · 2016
    11. Nilotinib-Induced Keratosis Pilaris Case Reports in Dermatology · 2016
    12. Vemurafenib-Induced Pityriasis Amiantacea: A Case Report Cutaneous and ocular toxicology · 2015
    13. Alopecia in Patients Treated with Molecularly Targeted Anticancer Therapies Annals of Oncology · 2015
    14. Unique Cutaneous Reaction to Second- and Third-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia Dermatology · 2015
    15. RASopathic Alopecia: Hair Changes Associated with Vemurafenib Therapy Journal of The American Academy of Dermatology · 2015
    16. Cutaneous Adverse Effects of Targeted Therapies Journal of the American Academy of Dermatology · 2015
    17. Cutaneous Adverse Effects of Targeted Therapies Journal of the American Academy of Dermatology · 2015
    18. Hair Loss and Hedgehog Inhibitors: A Class Effect? British Journal of Dermatology · 2014
    19. Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management Dermatology research and practice · 2014
    20. A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib JAMA Dermatology · 2013
    21. Advances in the Management of Cutaneous Toxicities of Targeted Therapies Seminars in Oncology · 2012
    22. A Case of Cicatricial Alopecia Associated with Erlotinib Annals of Dermatology · 2011
    23. Tufted Hair Folliculitis in a Woman Treated with Trastuzumab Targeted Oncology · 2010
    24. Cetuximab-Induced Hypertrichosis of the Scalp and Eyelashes Journal of The American Academy of Dermatology · 2010
    25. A Case Report of Inflammatory Nonscarring Alopecia Associated with the Epidermal Growth Factor Receptor Inhibitor Erlotinib Journal of Cutaneous Pathology · 2009
    26. Modulation of Hair Growth with Small Molecule Agonists of the Hedgehog Signaling Pathway Journal of Investigative Dermatology · 2005
    27. Epidermal Growth Factor as a Biological Switch in Hair Growth Cycle Journal of biological chemistry/˜The œJournal of biological chemistry · 2003
    28. Tyrosine Kinase Inhibition and Grey Hair The Lancet · 2003

    Related research 2

    1. Clinical Management of Cutaneous Adverse Events in Patients on Targeted Anticancer Therapies and Immunotherapies: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology Clinical & Translational Oncology · 2018
    2. Alopecia in Patients Treated with Molecularly Targeted Anticancer Therapies Annals of Oncology · 2015